- ►shouxi.net G Contreras, V Pardo, B Leclercq, O Lenz, E … - New England Journal of Medicine, 2004 - content.nejm.org Methods Fifty-nine patients with lupus nephritis (12 in World Health
Organization class III, 46 in class IV, and 1 in class Vb) received induction
therapy consisting of a maximum of seven monthly boluses of intravenous ... Cited by 406 - Related articles - BL Direct - All 7 versions
- ►shouxi.net EM Ginzler, MA Dooley, C Aranow, MY Kim, J … - The New England journal of medicine, 2005 - nejm.highwire.org Methods We conducted a 24-week randomized, open-label, noninferiority trial
comparing oral mycophenolate mofetil (initial dose, 1000 mg per day, increased
to 3000 mg per day) with monthly intravenous cyclophosphamide (0.5 g per ... Cited by 308 - Related articles - BL Direct - All 9 versions
FA Houssiau, C Vasconcelos, D D'Cruz, GD … - Rheumatology, 2002 - medscape.com Houssiau and colleagues [1,2] present a multicenter, prospective clinical trial
(the Euro-Lupus Nephritis Trial [1] ), that randomly assigned 90 systemic lupus
erythematosus (SLE) patients with proliferative glomerulonephritis to a ... Cited by 266 - Related articles - BL Direct - All 7 versions
- ►annals.org [PDF] GG Illei, HA Austin III, M Crane, L Collins, … - Annals of internal medicine, 2001 - Am Coll Physicians Gabor G. Illei, MD; Howard A. Austin III, MD; Marianna Crane, NP; Lee Collins,
MS; Mark F. Gourley, MD; Cheryl H. Yarboro, RN; Ellen M. Vaughan, MSN; Takashi
Kuroiwa, MD; Carol L. Danning, MD; Alfred D. Steinberg, MD; John H. ... Cited by 223 - Related articles - BL Direct - All 4 versions
DT Boumpas, R Furie, S Manzi, GG Illei, DJ … - Arthritis and rheumatism, 2003 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 176 - Related articles - BL Direct - All 4 versions
VK Bansal, JA Beto - American Journal of Kidney Diseases, 1997 - Elsevier The best therapeutic choice in lupus nephritis remains shrouded in a body of
controversial literature. The purpose of this review was to assess and compare
by meta-analysis the efficacy of therapeutic agents used in the treatment ... Cited by 156 - Related articles - BL Direct - All 10 versions
- ►nefrouruguay.com [PDF] SM Korbet, EJ Lewis, MM Schwartz, M … - American Journal of Kidney Diseases, 2000 - Elsevier In 1992, we published the results of a prospective, controlled trial of
aggressive therapy (high-dose prednisone plus oral cyclophosphamide alone or
with plasmapheresis) in 86 patients with severe lupus nephritis. During ... Cited by 135 - Related articles - BL Direct - All 4 versions
FA Houssiau, C Vasconcelos, D D'Cruz, GD … - Arthritis Care & Research - interscience.wiley.com In the Euro-Lupus Nephritis Trial (ELNT), 90 patients with lupus nephritis were
randomly assigned to a high-dose intravenous cyclophosphamide (IV CYC) regimen
(6 monthly pulses and 2 quarterly pulses with escalating doses) or a ... Cited by 118 - Related articles - All 6 versions
GG Illei, K Takada, D Parkin, HA Austin, M … - Arthritis Care & Research - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 118 - Related articles - BL Direct - All 3 versions
M Petri, RJ Jones, RA Brodsky - Arthritis and rheumatism, 2003 - assets0.pubget.com Objective. High-dose chemotherapy followed by hematopoietic stem cell
transplantation is increasingly being studied as a treatment for severe
autoimmune disorders, such as systemic lupus erythematosus (SLE). High-dose ... Cited by 105 - Related articles - View as HTML - BL Direct - All 5 versions
